Nutex Health Inc. (NUTX) stock
NUTXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3072% below fair value
$172.74−1.77 (-1.01%)
Close on Nov 18, 2026Market cap $1.18BP/E 6.8Yield –
Nutex Health free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Nutex Health's free cash flow for the twelve months ending Jun 30, 2026 was $274.17M, up 229.4% year over year. For fiscal 2025 it was $245.60M, up 1078.0% from the year before. The highest annual figure on record is $245.60M in fiscal 2025.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $245.60M | +1078.0% |
| FY2024 | Dec 31, 2024 | $20.85M | – |
| FY2023 | Dec 31, 2023 | -$8.24M | -122.9% |
| FY2022 | Dec 31, 2022 | $35.97M | -73.6% |
| FY2021 | Dec 31, 2021 | $136.51M | +435.7% |
| FY2020 | Dec 31, 2020 | $25.48M | – |
| FY2019 | Dec 31, 2019 | -$4.12M | – |
| FY2018 | Dec 31, 2018 | -$480.05K | -1127.9% |
| FY2015 | Dec 31, 2015 | $46.70K | -71.0% |
| FY2014 | Dec 31, 2014 | $161.23K | – |
| FY2012 | Dec 31, 2012 | -$510.63K | – |
| FY2011 | Dec 31, 2011 | -$639.75K | – |
| FY2010 | Dec 31, 2010 | -$1.63M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $31.66M | +19.4% |
| Q1 FY2026 | Mar 31, 2026 | $74.32M | +46.0% |
| Q4 FY2025 | Dec 31, 2025 | $68.98M | – |
| Q3 FY2025 | Sep 30, 2025 | $99.21M | +1507.7% |
| Q2 FY2025 | Jun 30, 2025 | $26.51M | +108.7% |
| Q1 FY2025 | Mar 31, 2025 | $50.90M | +2095.9% |
| Q4 FY2024 | Dec 31, 2024 | -$341.00K | – |
| Q3 FY2024 | Sep 30, 2024 | $6.17M | – |
| Q2 FY2024 | Jun 30, 2024 | $12.70M | +2.5% |
| Q1 FY2024 | Mar 31, 2024 | $2.32M | – |
| Q2 FY2023 | Jun 30, 2023 | -$3.06M | -131.7% |
| Q1 FY2023 | Mar 31, 2023 | -$3.32M | -112.2% |
| Q4 FY2022 | Dec 31, 2022 | $12.39M | -64.3% |
| Q3 FY2022 | Sep 30, 2022 | -$13.19M | -163.5% |
| Q2 FY2022 | Jun 30, 2022 | $9.63M | -88.2% |
| Q1 FY2022 | Mar 31, 2022 | $27.15M | – |
| Q4 FY2021 | Dec 31, 2021 | $34.70M | +28.3% |
| Q3 FY2021 | Sep 30, 2021 | $20.76M | – |
| Q2 FY2021 | Jun 30, 2021 | $81.61M | – |
| Q1 FY2021 | Mar 31, 2021 | -$567.06K | – |
| Q4 FY2020 | Dec 31, 2020 | $27.04M | – |
| Q3 FY2020 | Sep 30, 2020 | -$189.77K | – |
| Q2 FY2020 | Jun 30, 2020 | -$495.24K | – |
| Q1 FY2020 | Mar 31, 2020 | -$872.99K | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.48M | -6514.9% |
| Q3 FY2019 | Sep 30, 2019 | -$872.75K | – |
| Q2 FY2019 | Jun 30, 2019 | -$866.26K | – |
| Q1 FY2019 | Mar 31, 2019 | -$906.56K | – |
| Q3 FY2016 | Sep 30, 2016 | $23.06K | – |
See a number that looks wrong?